Capnopharm’s CapnoPen for aerosolizing chemotherapy receives CE mark
Capnopharm’s new CapnoPen CP-001k has received CE certification (MDR) for aerosolizing chemotherapy, DNA, RNA, nanomolecules, viruses, and immunotherapy into body cavities. As the only nebulizer with such certification, the new CapnoPen is setting a new regulatory standard in Intraperitoneal Chemotherapy.